- Home
- MPWR vs IQV Comparison
MPWR vs IQV Comparison
Compare MPWR & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPWR
- IQV
- Stock Information
- Founded
- MPWR 1997
- IQV 1982
- Country
- MPWR United States
- IQV United States
- Employees
- MPWR N/A
- IQV N/A
- Industry
- MPWR Semiconductors
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MPWR Technology
- IQV Health Care
- Exchange
- MPWR Nasdaq
- IQV Nasdaq
- Market Cap
- MPWR 38.6B
- IQV 31.0B
- IPO Year
- MPWR 2004
- IQV 2013
- Fundamental
- Price
- MPWR $840.38
- IQV $190.64
- Analyst Decision
- MPWR Strong Buy
- IQV Strong Buy
- Analyst Count
- MPWR 13
- IQV 20
- Target Price
- MPWR $855.31
- IQV $229.15
- AVG Volume (30 Days)
- MPWR 499.6K
- IQV 1.2M
- Earning Date
- MPWR 10-29-2025
- IQV 10-30-2025
- Dividend Yield
- MPWR 0.74%
- IQV N/A
- EPS Growth
- MPWR 358.16
- IQV N/A
- EPS
- MPWR 38.48
- IQV 6.92
- Revenue
- MPWR $2,543,912,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- MPWR $27.04
- IQV $6.01
- Revenue Next Year
- MPWR $15.41
- IQV $5.05
- P/E Ratio
- MPWR $21.84
- IQV $27.54
- Revenue Growth
- MPWR 34.30
- IQV 3.60
- 52 Week Low
- MPWR $438.86
- IQV $134.65
- 52 Week High
- MPWR $954.00
- IQV $248.03
- Technical
- Relative Strength Index (RSI)
- MPWR 53.43
- IQV 56.26
- Support Level
- MPWR $800.97
- IQV $183.10
- Resistance Level
- MPWR $869.70
- IQV $191.86
- Average True Range (ATR)
- MPWR 25.00
- IQV 4.93
- MACD
- MPWR -3.39
- IQV -0.57
- Stochastic Oscillator
- MPWR 50.18
- IQV 83.19
About MPWR Monolithic Power Systems Inc.
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.